Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
This invention describes the use of at least one compound with a progesterone-antagonistic (PA) action and at least one compound with an antiestrogenic (AE) action, each in a non-ovulation-inhibiting dosage in a single dosage unit, for the production of pharmaceutical agents for female contraception.
-
(2008/06/13)
Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
Competitive progesterone antagonists (antigestagens) are suitable for the production of pharmaceutical agents for the treatment of forms of dysfunctional uterine bleeding (metrorrhagias, menorrhagias, hypermenorrhea).
-
(2008/06/13)
Use of antigestagens for softening the nonpregnant cervix
Antigestagens are useful for softening the nonpregnant cervix.
-
(2008/06/13)
More Articles about downstream products of 96346-61-1